Symbolbild · KI-generiert
Perimeter Medical Imaging AI Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Claire, recently approved by the FDA, is our next-generation AI-enabled device. The Company's ticker symbol 'PINK' is a reference to the pink ribbons used during Breast Cancer Awareness Month. Indications for Use: The Claire OCT System is an adjunctive three-dimensional imaging tool which provides volumetric cross-sectional, real-time depth visualization, coupled with an artificial intelligence computer-aided detection algorithm which identifies and marks focal areas suspicious for breast cancer. It is used concurrently with physician interpretation of the images.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Perimeter Medical Imaging AI Inc. | PINK | TSXV | 32 Mio. USD |
| MedMira Inc. | MIR | TSXV | 32 Mio. USD |
| NexgenRx Inc. | NXG | TSXV | 33 Mio. USD |
| BetterLife Pharma Inc. | BETR | CSE | 33 Mio. USD |
| Vext Science, Inc. | VEXT | CSE | 34 Mio. USD |
| LSL Pharma Group Inc. | LSL | TSXV | 34 Mio. USD |
| NurExone Biologic Inc. | NRX | TSXV | 30 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.